Proline-rich nuclear receptor coactivator 2 pseudogene (PNRC2 pseudogene)

The proline-rich nuclear receptor coactivator 2 pseudogene (ENSG00000225385) is a genomic locus sharing sequence similarity with the functional PNRC2 gene, but due to disabling mutations (such as frameshifts, premature stop codons, or loss of regulatory elements), it cannot encode a functional protein product[1][5]. Pseudogenes are typically classified as DNA segments that resemble real genes but are inactive, and may arise from gene duplication (unprocessed pseudogenes) or retrotransposition (processed pseudogenes)[1][5]. While most pseudogenes are biologically inert, recent insights suggest some can regulate gene expression through mechanisms such as antisense RNA or serving as a source for long non-coding RNA transcripts[4][7]. However, there is no specific evidence that ENSG00000225385 fulfills such a regulatory role or is clinically relevant[3][5]. It is not a therapeutic target, lacks evidence for involvement in disease, and is not considered a receptor, enzyme, transporter, or other protein class typically associated with drug development[3][5].\n\nIf structured information is required for a therapeutic program, this pseudogene should be excluded as an actionable target.

Other names

PNRC2ENSG00000225385

None